Navigating the Digital Transformation for Biopharmaceutical Process Development: Harnessing the Power of Microbial Systems and Innovative Technologies



07th March 2024 | 10:00am EST / 7:00am PST / 3:00pm GMT / 4:00pm CET | Cecile Brocard, Director, Head of Downstream Development at Boehringer Ingelheim |WATCH FOR FREE

In this webinar, we will explore biopharmaceutical process development using microbial systems, such as bacteria and yeast. Key aspects include optimization of target protein expression, downstream process development, and high throughput approaches for rapid parameter screening.

The innovative smart Process Design platform will be central to the webinar, streamlining workflows and considering capacity limitations during process development. The importance of automation, parallelization, and integrated process models will be highlighted, enhancing efficiency, and facilitating data-driven decision-making for continuous improvement in bioprocess development.

The webinar will emphasize the unwavering commitment to leveraging advanced technologies and data-driven strategies in delivering innovative bioprocess solutions. This dedication drives the digital transformation of the biopharmaceutical industry, ensuring its position at the forefront of scientific and technological advancements.

Attendees will gain insights into the latest trends and best practices in biopharmaceutical process development using microbial systems. The webinar will underscore the significance of adopting a forward-thinking approach to process development, leading to more efficient, cost-effective, and sustainable solutions for the biopharmaceutical industry.

Presented by Cecile Brocard, Director, Head of Downstream Development at Boehringer Ingelheim

Cecile Brocard, Director, Head of Downstream Development at Boehringer Ingelheim presents a webinar on Navigating the Digital Transformation for Biopharmaceutical Process Development: Harnessing the Power of Microbial Systems and Innovative Technologies

Cécile Brocard, a trained biochemist, and molecular cell biologist, holds a degree in Biochemistry and Molecular Cell Biology from France and a PhD in Biochemistry from the prestigious University of Vienna, Austria. Currently, she serves as the Director of Downstream Development in the Process Science department at Boehringer Ingelheim Regional Center Vienna. Leading a talented team, Cécile is responsible for developing downstream processes for various recombinant proteins expressed in microbials, crucial for clinical supplies for phase I, II, and III trials, and overseeing tech transfer to production. Her team includes two downstream development units and a non-GMP pilot plant. Under Cécile’s leadership, they have driven technology programs and strategic initiatives within the organization, fostering innovation and improving process flows. As a speaker and participant in international conferences, Cécile Brocard aims to bring her knowledge and experience to the forefront, contributing to the advancement of biotechnology on a global scale.


We will not sell your information to a third party. See our Privacy Policy

Biopharma Webinars